Literature DB >> 30844489

Polysaccharide of Schisandra Chinensis Fructus ameliorates cognitive decline in a mouse model of Alzheimer's disease.

Mengjie Xu1, Tingxu Yan2, Kaiyue Fan1, Mengshi Wang1, Yu Qi1, Feng Xiao2, Kaishun Bi3, Ying Jia4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Polysaccharides is an important ingredient of Schisandra Chinensis Fructus which often appears in ancient prescriptions for forgetfulness or dementia. AIM OF THE STUDY: The purpose of our study is to investigate the effects of polysaccharides of Schisandra Chinensis Fructus (SCP) on animal model of Alzheimer's disease (AD), which is a common disease of dementia, to elucidate the traditional medical theories with modern pharmacological methods and provide a reference for further clarifying its active mechanisms.
MATERIALS AND METHODS: Hydrolysates of SCP were analyzed by HPLC. Y-maze, Morris water maze (MWM) were used for evaluating cognition processes of mice. Immunohistochemistry (IHC) was used to detect the deposition of Aβ. The levels of cytokine expression including Tumor Necrosis Factor α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) in the hippocampus were detected by ELISA kits. Activation of astrocytes and microglia was assessed by immunofluorescence labeling GFAP and Iba-1. The phosphorylated state of various mitogen-activated protein kinase (MAPKs) signaling molecules (p38 MAPK, ERK 1/2, and JNK) and activation of nuclear factor κB (NF-κB) was studied by western blot. Histopathological changes were observed by H.E. straining.
RESULTS: SCP could significantly improve the cognition and histopathological changes of AD mice, reduce the deposition of Aβ, downregulate the expression of pro-inflammatory cytokines and the activation of glial cells in the hippocampus. Further, SCP decreased nuclear displacement of NF-κB and MAPKs phosphorylation.
CONCLUSIONS: SCP could improve the cognition of mice, and it may play an anti-AD role by activating the NF-κB/MAPK pathway to alleviate neuroinflammation.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; MAPKs; Neuroinflammation; Polysaccharides; Schisandra Chinensis Fructus

Mesh:

Substances:

Year:  2019        PMID: 30844489     DOI: 10.1016/j.jep.2019.02.046

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  Protective Effects of Polysaccharides in Neurodegenerative Diseases.

Authors:  Yinying Wang; Rongsha Chen; Zhongshan Yang; Qian Wen; Xia Cao; Ninghui Zhao; Jinyuan Yan
Journal:  Front Aging Neurosci       Date:  2022-07-04       Impact factor: 5.702

2.  Determination and Comparison of Short-Chain Fatty Acids in Serum and Colon Content Samples: Alzheimer's Disease Rat as a Case Study.

Authors:  Lin-Xiu Guo; Yue Tong; Jue Wang; Guo Yin; Hou-Shuang Huang; Long Zeng; Ping Wang; Jun-Peng Li; Kai-Shun Bi; Tie-Jie Wang
Journal:  Molecules       Date:  2020-12-04       Impact factor: 4.411

Review 3.  Neuroprotective effects of naturally sourced bioactive polysaccharides: an update.

Authors:  Xiao-Lan Xu; Song Li; Rong Zhang; Wei-Dong Le
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

4.  Marked Response of Rat Ileal and Colonic Microbiota After the Establishment of Alzheimer's Disease Model With Bilateral Intraventricular Injection of Aβ (1-42).

Authors:  Qing Xu; Lingmiao Wen; Guihua Wei; Xiaoqin Zhao; Yanjun Liu; Wei Xiong; Tinglan Zhang; Yuqing Fan; Chunlan Chen; Chunxiao Xiang; Chang Chen; Yunhui Chen; Qiaozhi Yin; Tian-E Zhang; Zhiyong Yan
Journal:  Front Microbiol       Date:  2022-02-11       Impact factor: 5.640

Review 5.  Pharmacodynamic material basis of traditional Chinese medicine based on biomacromolecules: a review.

Authors:  Wen-Jin Zhang; Sheng Wang; Chuan-Zhi Kang; Chao-Geng Lv; Li Zhou; Lu-Qi Huang; Lan-Ping Guo
Journal:  Plant Methods       Date:  2020-02-28       Impact factor: 4.993

Review 6.  Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases.

Authors:  Manel Dhahri; Mawadda Alghrably; Hamdoon A Mohammed; Syed Lal Badshah; Noreen Noreen; Fouzi Mouffouk; Saleh Rayyan; Kamal A Qureshi; Danish Mahmood; Joanna Izabela Lachowicz; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.